Related Experiment Video
Updated: Jun 26, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein
Anshuman Dixit1, Ali Torkamani, Nicholas J Schork
1Center for Bioinformatics, The University of Kansas, Lawrence, Kansas, USA.
Abstract:
Structural and biochemical characterization of protein kinases that confer oncogene addiction and harbor a large number of disease-associated mutations, including RET and MET kinases, have provided insights into molecular mechanisms associated with the protein kinase activation in human cancer. In this article, structural modeling, molecular dynamics, and free energy simulations of a structurally conserved mutational hotspot, shared by M918T in RET and M1250T in MET kinases, are undertaken to quantify the molecular mechanism of activation and the functional role of cancer mutations in altering protein kinase structure, dynamics, and stability. The mechanistic basis of the activating RET and MET cancer mutations may be driven by an appreciable free energy destabilization of the inactive kinase state in the mutational forms. According to our results, the locally enhanced mobility of the cancer mutants and a higher conformational entropy are counterbalanced by a larger enthalpy loss and result in the decreased thermodynamic stability. The computed protein stability differences between the wild-type and cancer kinase mutants are consistent with circular dichroism spectroscopy and differential scanning calorimetry experiments. These results support the molecular mechanism of activation, which causes a detrimental imbalance in the dynamic equilibrium shifted toward the active form of the enzyme. Furthermore, computer simulations of the inhibitor binding with the oncogenic and drug-resistant RET mutations have also provided a plausible molecular rationale for the observed differences in the inhibition profiles, which is consistent with the experimental data. Finally, structural mapping of RET and MET cancer mutations and the computed protein stability changes suggest a similar mechanism of activation, whereby the cancer mutations which display the higher oncogenic activity tend to have the greatest destabilization effect on the inactive kinase structure.
Insights
Cancer mutations in RET and MET kinases destabilize their inactive state, promoting activation. This molecular mechanism, involving altered dynamics and stability, explains oncogene addiction and drug resistance in cancer therapies.
Area of Science:
- Biochemistry
- Structural Biology
- Computational Biology
Background:
- Protein kinases like RET and MET are crucial in human cancer, often driven by mutations causing oncogene addiction.
- Understanding kinase activation mechanisms is key to developing targeted cancer therapies.
Purpose of the Study:
- To investigate the molecular mechanism of activation for RET and MET kinases harboring cancer mutations.
- To quantify how mutations alter protein kinase structure, dynamics, and stability.
- To explore the impact of mutations on inhibitor binding and drug resistance.
Main Methods:
- Structural modeling
- Molecular dynamics simulations
- Free energy simulations
- Circular dichroism spectroscopy
- Differential scanning calorimetry
Main Results:
- Cancer mutations significantly destabilize the inactive kinase state, shifting the equilibrium towards the active form.
- Mutations increase local mobility and conformational entropy, but enthalpy loss decreases overall thermodynamic stability.
- Computed stability changes correlate with experimental data (CD, DSC).
- Simulations explain differential inhibitor binding to wild-type vs. mutant kinases, consistent with observed drug resistance.
Conclusions:
- Activating cancer mutations in RET and MET kinases function by destabilizing the inactive conformation.
- This destabilization creates a dynamic imbalance favoring the active enzyme state.
- A similar activation mechanism is suggested for RET and MET mutations, with higher oncogenic activity correlating with greater destabilization.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
